Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,590 | 451 | 97.5% |
| Education | $191.49 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $890.81 | 30 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $631.79 | 32 | $0 (2024) |
| Novo Nordisk Inc | $535.22 | 35 | $0 (2024) |
| PFIZER INC. | $516.78 | 37 | $0 (2024) |
| Amgen Inc. | $508.59 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $501.51 | 37 | $0 (2024) |
| ABBVIE INC. | $330.94 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $304.03 | 18 | $0 (2024) |
| Lilly USA, LLC | $303.90 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $284.55 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,277 | 57 | AstraZeneca Pharmaceuticals LP ($320.59) |
| 2023 | $1,345 | 72 | AstraZeneca Pharmaceuticals LP ($233.28) |
| 2022 | $1,048 | 65 | AstraZeneca Pharmaceuticals LP ($134.82) |
| 2021 | $1,374 | 80 | AbbVie Inc. ($149.59) |
| 2020 | $1,237 | 78 | Teva Pharmaceuticals USA, Inc. ($169.69) |
| 2019 | $1,038 | 73 | Novo Nordisk Inc ($214.50) |
| 2018 | $449.62 | 27 | Boehringer Ingelheim Pharmaceuticals, Inc. ($107.88) |
| 2017 | $13.47 | 1 | Biofrontera Inc. ($13.47) |
All Payment Transactions
453 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Central Nervous System | ||||||
| 11/13/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: WATCHMAN_IC | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: WOMENS HEALTH | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: PSYCHIATRY | ||||||
| 07/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Central Nervous System | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,215 | 3,937 | $319,699 | $204,779 |
| 2022 | 39 | 3,288 | 6,428 | $509,540 | $203,646 |
| 2021 | 55 | 5,878 | 11,577 | $714,593 | $344,287 |
| 2020 | 51 | 6,198 | 10,675 | $695,813 | $292,282 |
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 582 | 1,881 | $245,547 | $162,430 | 66.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 26 | 144 | $16,048 | $10,947 | 68.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $15,739 | $10,634 | 67.6% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 16 | 90 | $13,671 | $8,244 | 60.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 116 | 306 | $5,173 | $3,052 | 59.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $4,006 | $2,945 | 73.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 33 | 56 | $4,038 | $2,635 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $2,792 | $1,858 | 66.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 21 | 21 | $1,313 | $1,003 | 76.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 113 | 155 | $2,345 | $616.79 | 26.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 16 | 17 | $239.36 | $240.04 | 100.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 122 | 181 | $807.00 | $145.52 | 18.0% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 920 | $7,900 | $21.48 | 0.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 14 | $81.00 | $5.68 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 603 | 1,702 | $286,958 | $114,913 | 40.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 54 | 246 | $32,813 | $15,242 | 46.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 780 | $16,380 | $12,729 | 77.7% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 30 | 163 | $34,572 | $11,614 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $15,286 | $5,552 | 36.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 407 | 477 | $14,787 | $4,996 | 33.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 314 | 342 | $15,048 | $4,528 | 30.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 231 | 247 | $10,374 | $4,124 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 81 | $9,127 | $3,741 | 41.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 33 | 43 | $9,139 | $3,453 | 37.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 313 | 358 | $6,444 | $2,763 | 42.9% |
About Dr. Jacob Hostetler, M.D
Dr. Jacob Hostetler, M.D is a Family Medicine healthcare provider based in Grove, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1265829485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Hostetler, M.D has received a total of $7,781 in payments from pharmaceutical and medical device companies, with $1,277 received in 2024. These payments were reported across 453 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,590).
As a Medicare-enrolled provider, Hostetler has provided services to 16,579 Medicare beneficiaries, totaling 32,617 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Grove, OK
- Active Since 04/26/2015
- Last Updated 11/13/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265829485
Products in Payments
- FARXIGA (Drug) $569.61
- TRELEGY ELLIPTA (Drug) $453.85
- Ozempic (Drug) $405.69
- REXULTI (Drug) $320.17
- AUSTEDO (Drug) $315.78
- VRAYLAR (Drug) $287.06
- Kerendia (Drug) $284.55
- JARDIANCE (Drug) $283.15
- TRINTELLIX (Drug) $248.06
- Otezla (Drug) $218.54
- Aimovig (Biological) $198.03
- GEMTESA (Drug) $186.34
- BREZTRI (Drug) $185.11
- TRULANCE (Drug) $169.63
- HETLIOZ (Drug) $159.37
- XARELTO (Drug) $159.36
- TRULICITY (Drug) $157.53
- MYRBETRIQ (Drug) $145.74
- Austedo XR (Drug) $108.87
- NOURIANZ (Drug) $106.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Grove
Dr. Jenny Walsh, M.d, M.D
Family Medicine — Payments: $2,492
Dr. Charles Chouteau, Md, MD
Family Medicine — Payments: $2,435
Dr. Phillip Williams, Do, DO
Family Medicine — Payments: $835.37
Daniel Nicoll, Do, DO
Family Medicine — Payments: $426.45
Dr. Trevor Kitchens, Md, MD
Family Medicine — Payments: $388.36
Dr. Kyle Schauf, Md, MD
Family Medicine — Payments: $223.70